CENPB and systemic sclerosis: Finally, anti-CENPB antibodies were shown to be present in 44% (four out of nine) of SSc cases with reflux, Raynaud, and digital ulcers, while almost completely absent in SSc subgroups with only one or two of these clinical manifestations (Figure 3d).